Propranolol Treatment for a Giant Infantile Brain Cavernoma

Journal of Child Neurology

Volumn 25, Issue 5, 2010, Pages 653-655

  Moschovi, Maria ^a   Alexiou, George A ^b   Stefanaki, Kalliopi ^b   Tourkantoni, Natalia ^a   Prodromou, Neofytos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; IRON; PROPRANOLOL;

BLOOD VESSEL; BRAIN; BRAIN HEMANGIOMA; BRAIN TUMOR; DRUG EFFECT; HUMAN; INFANT; LETTER; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TIME; TREATMENT OUTCOME;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BLOOD VESSELS; BRAIN; BRAIN NEOPLASMS; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; INFANT; IRON; MAGNETIC RESONANCE IMAGING; MALE; PROPRANOLOL; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953287004     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073810363917     Document Type: Article

References (3)

1. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008; 358: 2649-2651.
2. D’Angelo G., Lee H., Weiner RI cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem. 1997; 67: 353-366.
3. Sommers Smith SK, Smith DM Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002; 38: 298-304.